Canada · Delayed Price · Currency is CAD Richards Group Earnings Call Transcripts
Fiscal Year 2026
-
Revenue grew 5% year-to-date, led by healthcare and acquisitions, while packaging declined due to U.S. macro headwinds. Gross margins improved, free cash flow conversion rose to 67%, and leverage remains comfortable after significant buybacks and acquisitions.
-
Revenue grew 5% year-over-year to CAD 105 million, led by healthcare and acquisitions, while packaging declined. Gross margin improved to 44%, but EBITDA was flat due to higher OpEx from OEM investments. Major share buybacks and a CAD 13.5 million acquisition expanded the healthcare portfolio.
Fiscal Year 2025
-
Revenue rose 5.5% year-over-year, led by healthcare acquisitions, while adjusted EBITDA margin declined to 13% due to higher costs. The company executed major M&A, expanded globally, and launched a long-term strategy focused on organic and international growth.